Perceptive Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $24.6 Million - $30.2 Million	-55,175 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $24 Million - $30.5 Million	50,175 Added 1003.5%	55,175 $26.7 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $5.45 Million - $6.58 Million	-10,000 Reduced 66.67%	5,000 $2.8 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $32.1 Million - $41.9 Million	-65,000 Reduced 81.25%	15,000 $9.35 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $20.2 Million - $29.7 Million	60,000 Added 300.0%	80,000 $39.1 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $7.17 Million - $9.4 Million	20,000	20,000 $7.52 Million

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.